Login / Signup

Persistence of peripheral CD8 + CD28- T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer.

Xiao-Ran LiuXiangming ChengFeng XieKun LiYongcan ShiBin ShaoXu LiangFengling WanShidong JiaYue ZhangYiqiang LiuHuiping Li
Published in: British journal of cancer (2024)
level is associated with a favourable tumour immunity and a better PFS of HER2-targeting therapy in MBC patients.
Keyphrases
  • metastatic breast cancer
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • stem cells
  • cancer therapy
  • bone marrow
  • nk cells